Hypermethylation of MDFI promoter with NSCLC is specific for females, non-smokers and people younger than 65

Non-small cell lung carcinoma (NSCLC) is a major subtype of lung cancer. Aberrant DNA methylation has been frequently observed in NSCLC. The aim of the present study was to investigate the role of MyoD family inhibitor (MDFI) methylation in NSCLC. Formalin-fixed paraffin-embedded tumor tissues and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Hongying, Chen, Xiaoying, Hu, Haochang, Li, Bin, Ying, Xiuru, Zhou, Cong, Zhong, Jie, Zhao, Guofang, Duan, Shiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958687/
https://www.ncbi.nlm.nih.gov/pubmed/29805634
http://dx.doi.org/10.3892/ol.2018.8535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958687/
https://www.ncbi.nlm.nih.gov/pubmed/29805634
http://dx.doi.org/10.3892/ol.2018.8535

Ejemplares similares